Abstract
Increasing evidence suggests an association between gene expression and clinical pain. Epigenetic modifications are the main modulators of gene expression or protein translation in response to environmental stimuli and pathophysiological conditions. Preclinical and clinical studies indicate that epigenetic modifications could also impact the development of pain, the transition from acute to chronic pain, and the maintenance hereof.
Main text
Epigenetics can be defined as the study of mechanisms that induce changes in the phenotypes without altering the main sequence of the DNA [1]. Epigenetic processes include three major mechanisms (1) DNA methylation, (2) histone modifications, and (3) the action of non-coding RNA (ncRNA) [2], [3], [4]. The application of epigenetics in pain research is progressing fast and studies have revealed epigenetic mechanisms underlying acute pain [5], [6], [7].
One way to assess somatosensory changes and evaluate allodynia, hyperalgesia, hypoesthesia, or hypoalgesia is through standardized quantitative sensory testing (QST) [8]. QST can include a series of tests for detection of thermal and mechanical thresholds, thresholds for pain after several stimuli, suprathreshold pinprick tests and wind-up, plus specific assessment for dynamic mechanical allodynia, paradoxical heat sensation, and the assessments targeting the descending pain inhibitory systems [8]. Accumulating evidence suggests that pre-treatment QST might hold a predictive value for treatment responses to standard pain treatments [9], [10], [11], [12]. This summary aims to explain the involvement of epigenetics in pain research and its potential association with QST.
DNA methylation occurs mostly on cytosine-5-carbon at the CpG dinucleotide island site, where the DNA methyltransferase (DNMT) enzyme catalyzes the addition of methyl (CH3) groups [1], which leads to inhibition and silencing of the gene expression [6, 13, 14]. A preclinical study has shown that reversing methylation responses through intrathecal injection of DNMT inhibitors, reduces mechanical and thermal hyperalgesia in a rat model [15]. Moreover, heat pain sensitivity has been shown to be associated with hypermethylation in the promoter region of the TRPA1 gene expressed in peripheral nociceptors and pain-sensitivity scores in a study with 100 volunteers [16].
Histone modification and chromatin remodeling, are changes that happen at the nucleosome level, which is the basic unit of chromatin, and consist of 140 base pairs of DNA wrapped around a histone octamer (proteins H1/H5, H2A, H2B, H3, and H4) [17]. The terminal portion of histones protrudes from the nucleosome and is the site where post-transcriptional modification such as acetylation and methylation can occur [17]. Preclinical studies have shown that acetylation and methylation of promoter regions of genes that code for the µ-receptor, Nav1.8, and Kv4.3 can either attenuate or induce hyperalgesia [17].
Non-coding RNAs (ncRNAs) include short-ncRNAs such as microRNAs (miRNAs) and long ncRNAs (lncRNAs). The main function of ncRNAs is to regulate gene expression at the transcriptional and translational levels and their expression is influenced by environmental or external stimuli, confirming the concept of epigenetic regulation independently from the DNA sequences [4]. Despite many studies highlighting the involvement of miRNAs and lncRNA in pain states [18, 19], this is still an emerging field within pain research that needs further attention [20]. Studies have found that preoperative circulating long- and miRNAs are associated with chronic postoperative pain one year after total knee arthroplasty [21], [22], [23], which could indicate that certain long- and miRNA might hold prognostic information. Studies have demonstrated that in silico target prediction models can identify pathways of regulations that involved miRNAs and lncRNAs, that are associated with the regulation of interleukin 1β (IL-1 beta), IL-6, and TNF-alpha [21], [22], [23], which are well known pro-inflammatory cytokines involved in the sensitization of nociceptors [24].
The field of epigenetics and pain is an emerging field, which potentially can highlight aspects of how pain is regulated at a transcriptional and translational level. Some studies can link epigenetics to pain sensitivity but more research is needed. Emerging studies indicate that epigenetic markers might hold prognostic value and these findings should be investigated in future large-scale studies.
-
Research funding: The Center for Neuroplasticity and Pain (CNAP) is supported by the Danish National Research Foundation (DNRF121). Center for Mathematical Modeling of Knee Osteoarthritis (MathKOA), Department of Material and Production, Faculty of Engineering and Science, Aalborg University.
-
Competing interests: The authors have no conflict of interest to disclose.
References
1. Dupont, C, Armant, DR, Brenner, CA. Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med 2009;27:351–7. https://doi.org/10.1055/s-0029-1237423.Search in Google Scholar PubMed PubMed Central
2. Bali, KK, Gandla, J, Rangel, DR, Castaldi, L, Mouritzen, P, Agarwal, N, et al.. A genome-wide screen reveals microRNAs in peripheral sensory neurons driving painful diabetic neuropathy. Pain 2021;162:1334–51. https://doi.org/10.1097/j.pain.0000000000002159.Search in Google Scholar PubMed
3. Han, Q, Liu, D, Convertino, M, Wang, Z, Jiang, C, Kim, YH, et al.. miRNA-711 binds and activates TRPA1 extracellularly to evoke acute and chronic pruritus. Neuron 2018;99:449–63.e6. https://doi.org/10.1016/j.neuron.2018.06.039.Search in Google Scholar PubMed PubMed Central
4. Niederberger, E, Resch, E, Parnham, MJ, Geisslinger, G. Drugging the pain epigenome. Nat Rev Neurol 2017;13:434–47. https://doi.org/10.1038/nrneurol.2017.68.Search in Google Scholar PubMed
5. Géranton, SM, Tochiki, KK. Regulation of gene expression and pain states by epigenetic mechanisms. Prog Mol Biol Transl Sci 2015;131:147–83. https://doi.org/10.1016/bs.pmbts.2014.11.012.Search in Google Scholar PubMed
6. Doehring, A, Geisslinger, G, Lötsch, J. Epigenetics in pain and analgesia: an imminent research field. Eur J Pain 2011;15:11–6. https://doi.org/10.1016/j.ejpain.2010.06.004.Search in Google Scholar PubMed
7. Buchheit, T, van de Ven, T, Shaw, A. Epigenetics and the transition from acute to chronic pain. Pain Med 2012;13:1474–90. https://doi.org/10.1111/j.1526-4637.2012.01488.x.Search in Google Scholar PubMed PubMed Central
8. Rolke, R, Baron, R, Maier, C, Tölle, TR, Treede, RD, Beyer, A, et al.. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): standardized protocol and reference values. Pain 2006;123:231–43. https://doi.org/10.1016/j.pain.2006.01.041.Search in Google Scholar PubMed
9. Hansen, S, Vaegter, HB, Petersen, KK. Pretreatment exercise-induced hypoalgesia is associated with change in pain and function after standardized exercise therapy in painful knee osteoarthritis. Clin J Pain 2020;36:16–24. https://doi.org/10.1097/AJP.0000000000000771.Search in Google Scholar PubMed
10. Petersen, KK, Arendt-Nielsen, L, Simonsen, O, Wilder-Smith, O, Laursen, MB. Presurgical assessment of temporal summation of pain predicts the development of chronic postoperative pain 12 months after total knee replacement. Pain 2015;156:55–61. https://doi.org/10.1016/J.PAIN.0000000000000022.Search in Google Scholar PubMed
11. Petersen, KK, Olesen, AE, Simonsen, O, Arendt-Nielsen, L. Mechanistic pain profiling as a tool to predict the efficacy of 3-week nonsteroidal anti-inflammatory drugs plus paracetamol in patients with painful knee osteoarthritis. Pain 2019;160:486–92. https://doi.org/10.1097/J.PAIN.0000000000001427.Search in Google Scholar PubMed
12. Petersen, KK, Vaegter, HB, Stubhaug, A, Wolff, A, Scammell, BE, Arendt-Nielsen, L, et al.. The predictive value of quantitative sensory testing: a systematic review on chronic postoperative pain and the analgesic effect of pharmacological therapies in patients with chronic pain. Pain 2021;162:31–44. https://doi.org/10.1097/J.PAIN.0000000000002019.Search in Google Scholar PubMed
13. Sharma, S, Kelly, TK, Jones, PA. Epigenetics in cancer. Carcinogenesis 2009;31:27–36. https://doi.org/10.1093/carcin/bgp220.Search in Google Scholar PubMed PubMed Central
14. Nielsen, DA, Yuferov, V, Hamon, S, Jackson, C, Ho, A, Ott, J, et al.. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 2009;34:867–73. https://doi.org/10.1038/npp.2008.108.Search in Google Scholar PubMed PubMed Central
15. Wang, Y, Liu, C, Guo, QL, Yan, JQ, Zhu, XY, Huang, CS, et al.. Intrathecal 5-azacytidine inhibits global DNA methylation and methyl- CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injury. Brain Res 2011;1418:64–9. https://doi.org/10.1016/J.BRAINRES.2011.08.040.Search in Google Scholar PubMed
16. Bell, JT, Loomis, AK, Butcher, LM, Gao, F, Zhang, B, Hyde, CL, et al.. Differential methylation of the TRPA1 promoter in pain sensitivity. Nat Commun 2014;5:1–11. https://doi.org/10.1038/ncomms3978.Search in Google Scholar PubMed PubMed Central
17. Liang, L, Lutz, BM, Bekker, A, Tao, YX. Epigenetic regulation of chronic pain. Epigenomics 2015;7:235–42. https://doi.org/10.2217/epi.14.75.Search in Google Scholar PubMed PubMed Central
18. Li, Z, Li, X, Jian, W, Xue, Q, Liu, Z. Roles of long non-coding RNAs in the development of chronic pain. Front Mol Neurosci 2021;14:277. https://doi.org/10.3389/FNMOL.2021.760964/BIBTEX.Search in Google Scholar
19. Polli, A, Godderis, L, Ghosh, M, Ickmans, K, Nijs, J. Epigenetic and miRNA expression changes in people with pain: a systematic review. J Pain 2020;21:763–80. https://doi.org/10.1016/J.JPAIN.2019.12.002.Search in Google Scholar PubMed
20. Andersen, HH, Duroux, M, Gazerani, P. MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiol Dis 2014;71:159–68. https://doi.org/10.1016/j.nbd.2014.08.003.Search in Google Scholar PubMed
21. Giordano, R, Petersen, KK, Andersen, HH, Simonsen, O, Arendt-Nielsen, L. Serum inflammatory markers in patients with knee osteoarthritis: a proteomic approach. Clin J Pain 2020;36:229–37. https://doi.org/10.1097/AJP.0000000000000804.Search in Google Scholar PubMed
22. Giordano, R, Petersen, KK, Andersen, HH, Lichota, J, Valeriani, M, Simonsen, O, et al.. Preoperative serum circulating microRNAs as potential biomarkers for chronic postoperative pain after total knee replacement. Mol Pain 2020;16:174480692096292. https://doi.org/10.1177/1744806920962925.Search in Google Scholar PubMed PubMed Central
23. Giordano, R, Petersen, KK, Santoro, M, Pazzaglia, C, Simonsen, O, Valeriani, M, et al.. Circulating long non-coding RNA signature in knee osteoarthritis patients with postoperative pain one-year after total knee replacement. Scand J Pain 2021;21:823–30. https://doi.org/10.1515/SJPAIN-2021-0069/HTML.Search in Google Scholar
24. Schaible, HG. Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep 2012;14:549–56. https://doi.org/10.1007/s11926-012-0279-x.Search in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Articles
- Abstract for the special issue
- Short Communications
- The link between epigenetics, pain sensitivity and chronic pain
- Mapping emotions on the body
- Lessons learned – Moving on from QST sensory profiles
- Sensory testing might not be perfect – but it is the best biomarker for pain phenotypes we have right now
- Assessing pain after cancer treatment
- The distributed nociceptive system: a novel framework for understanding pain
- Visualizing and quantifying spatial and qualitative pain sensations
- Assessing the societal cost of chronic pain
- The Harald Breivik lecture 2022. Pathophysiology in persistent severe pain after groin hernia repair
Articles in the same Issue
- Frontmatter
- Articles
- Abstract for the special issue
- Short Communications
- The link between epigenetics, pain sensitivity and chronic pain
- Mapping emotions on the body
- Lessons learned – Moving on from QST sensory profiles
- Sensory testing might not be perfect – but it is the best biomarker for pain phenotypes we have right now
- Assessing pain after cancer treatment
- The distributed nociceptive system: a novel framework for understanding pain
- Visualizing and quantifying spatial and qualitative pain sensations
- Assessing the societal cost of chronic pain
- The Harald Breivik lecture 2022. Pathophysiology in persistent severe pain after groin hernia repair